Private Trust Company’s AstraZeneca AZN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $432K | Buy |
+2,309
| New | +$434K | 0.03% | 513 |
|
|
2026
Q1 | – | Sell |
-2,204
| Closed | -$405K | – | 2611 |
|
|
2025
Q4 | $405K | Buy |
2,204
+186
| +9% | +$32.6K | 0.04% | 511 |
|
|
2025
Q3 | $310K | Buy |
2,018
+44
| +2% | +$6.66K | 0.03% | 585 |
|
|
2025
Q2 | $276K | Buy |
1,974
+195
| +11% | +$27.3K | 0.03% | 605 |
|
|
2025
Q1 | $261K | Buy |
1,779
+43
| +2% | +$6.22K | 0.03% | 611 |
|
|
2024
Q4 | $227K | Sell |
1,736
-519
| -23% | -$72.7K | 0.02% | 642 |
|
|
2024
Q3 | $351K | Buy |
2,255
+244
| +12% | +$39.4K | 0.04% | 505 |
|
|
2024
Q2 | $314K | Buy |
2,011
+185
| +10% | +$27.8K | 0.03% | 509 |
|
|
2024
Q1 | $247K | Sell |
1,826
-17
| -0.9% | -$2.25K | 0.03% | 568 |
|
|
2023
Q4 | $248K | Buy |
1,843
+95
| +5% | +$12.3K | 0.03% | 538 |
|
|
2023
Q3 | $237K | Buy |
1,748
+508
| +41% | +$69.4K | 0.03% | 523 |
|
|
2023
Q2 | $177K | Buy |
1,240
+81
| +7% | +$11.9K | 0.02% | 603 |
|
|
2023
Q1 | $161K | Buy |
1,159
+67
| +6% | +$9.01K | 0.02% | 614 |
|
|
2022
Q4 | $148K | Sell |
1,092
-5
| -0.5% | -$627 | 0.02% | 604 |
|
|
2022
Q3 | $120K | Sell |
1,097
-62
| -5% | -$7.87K | 0.02% | 611 |
|
|
2022
Q2 | $153K | Sell |
1,159
-7,523
| -87% | -$987K | 0.02% | 556 |
|
|
2022
Q1 | $1.15M | Sell |
8,682
-6,717
| -44% | -$806K | 0.18% | 140 |
|
|
2021
Q4 | $1.79M | Sell |
15,399
-2,972
| -16% | -$350K | 0.25% | 107 |
|
|
2021
Q3 | $2.21M | Buy |
18,371
+14,291
| +350% | +$1.66M | 0.32% | 91 |
|
|
2021
Q2 | $489K | Buy |
4,080
+1,085
| +36% | +$119K | 0.07% | 264 |
|
|
2021
Q1 | $297K | Sell |
2,995
-739
| -20% | -$74.3K | 0.05% | 336 |
|
|
2020
Q4 | $373K | Buy |
3,734
+149
| +4% | +$15.8K | 0.06% | 280 |
|
|
2020
Q3 | $392K | Sell |
3,585
-4
| -0.1% | -$445 | 0.08% | 256 |
|
|
2020
Q2 | $386K | Sell |
3,589
-569
| -14% | -$58.8K | 0.08% | 249 |
|
|
2020
Q1 | $371K | Sell |
4,158
-1,083
| -21% | -$102K | 0.1% | 241 |
|
|
2019
Q4 | $522K | Buy |
5,241
+147
| +3% | +$13.8K | 0.1% | 254 |
|
|
2019
Q3 | $454K | Buy |
5,094
+151
| +3% | +$13.1K | 0.09% | 254 |
|
|
2019
Q2 | $408K | Buy |
4,943
+329
| +7% | +$25.8K | 0.08% | 264 |
|
|
2019
Q1 | $373K | Sell |
4,614
-289
| -6% | -$22.8K | 0.08% | 270 |
|
|
2018
Q4 | $372K | Sell |
4,903
-1,587
| -24% | -$124K | 0.09% | 251 |
|
|
2018
Q3 | $513K | Sell |
6,490
-64
| -1% | -$4.84K | 0.1% | 233 |
|
|
2018
Q2 | $460K | Buy |
6,554
+1,481
| +29% | +$107K | 0.1% | 243 |
|
|
2018
Q1 | $354K | Buy |
5,073
+602
| +13% | +$41.7K | 0.08% | 273 |
|
|
2017
Q4 | $310K | Buy |
+4,471
| New | +$302K | 0.07% | 291 |
|
|
2014
Q4 | – | Sell |
-628
| Closed | -$45K | – | 369 |
|
|
2014
Q3 | $45K | Sell |
628
-76
| -11% | -$5.56K | 0.02% | 575 |
|
|
2014
Q2 | $52K | Sell |
704
-138
| -16% | -$9.98K | 0.02% | 548 |
|
|
2014
Q1 | $55K | Sell |
842
-704
| -46% | -$45.5K | 0.02% | 474 |
|
|
2013
Q4 | $92K | Sell |
1,546
-31
| -2% | -$1.68K | 0.04% | 324 |
|
|
2013
Q3 | $82K | Buy |
1,577
+420
| +36% | +$21.1K | 0.04% | 328 |
|
|
2013
Q2 | $55K | Buy |
+1,157
| New | +$58.9K | 0.03% | 389 |
|
Other funds holding AZN
EP
IA
Private Trust Company's AZN Position: Q2 2026 in Review
Private Trust Company opened a new position in AstraZeneca (AZN) in Q2 2026: 2,309 shares worth $432K. The stake represents 0.03% of the portfolio and ranks #513 among its holdings. This is a return to the name: Private Trust Company previously reported a position in AZN as recently as Q4 2025.
Private Trust Company first reported a position in AZN in Q2 2013 and has held it in 40 quarters since. The position peaked at $2.21M in Q3 2021. 1,495 funds tracked by Wall St. Rank hold AZN as of Q2 2026.
- Private Trust Company held 2,309 shares of AstraZeneca worth $432K as of Q2 2026.
- AstraZeneca was a new Private Trust Company position in Q2 2026.
- AstraZeneca made up 0.03% of Private Trust Company's portfolio in Q2 2026, its #513 holding.
- Private Trust Company first reported a position in AstraZeneca in Q2 2013 and has held it in 40 quarters since.
- Private Trust Company's AstraZeneca position peaked at $2.21M in Q3 2021.
- 1,495 funds tracked by Wall St. Rank held AstraZeneca as of Q2 2026.
Based on Private Trust Company's 13F filing for Q2 2026, filed 28 Jul 2026.